Response as an end point in treatment trials for acute GVHD
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?
What are a patient's current chances of finding a matched unrelated donor? Twenty years’ central search experience in a small country
Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation
Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT
Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation
Allogeneic cellular gene therapy in hemoglobinopathies—evaluation of hematopoietic SCT in sickle cell anemia
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia
Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT
In vitro activation of CMV-specific human CD8+ T cells by adenylate cyclase toxoids delivering pp65 epitopes
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation
Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD
Long-term oral complications of allogeneic haematopoietic SCT
Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence
Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft
Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study
Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCT
Cardiac tamponade potentially related to sirolimus following cord blood transplantation
Thyroid dysfunction in adult patients late after autologous and allogeneic blood and marrow transplantation
Standardization of Aspergillus PCR diagnosis
Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT
Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors
Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioning
Pulmonary micro-embolism in a healthy donor following G-CSF administration for mobilization of hemopoietic progenitor cells
BU, melphalan and thiotepa as a preparative regimen for auto-transplantation in Hodgkin's disease
Fertility preservation in young patients before allogeneic haematopoietic SCT
Deferasirox increases BU blood concentrations
DRESS or ‘picture of DRESS’
CMV encephalitis in BMT recipients